StockData
Galectin Therapeutics Inc logo

Galectin Therapeutics Inc (GALT) stock

GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.98+0.07 (+2.41%)

Close on Nov 18, 2026Market cap $300.53MP/E –Yield –

Galectin Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Galectin Therapeutics's market cap was $218.17M on Nov 11, 2026, against $369.43M a year earlier. Over the last 5 years it ranged from $67.15M to $372.19M, with a median of $123.01M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$218.17M-18.7%
2025Dec 31, 2025$268.21M+233.7%
2024Dec 31, 2024$80.38M-21.7%
2023Dec 29, 2023$102.67M+52.9%
2022Dec 30, 2022$67.15M-45.3%
2021Dec 31, 2021$122.84M-3.9%
2020Dec 31, 2020$127.85M-21.1%
2019Dec 31, 2019$162.04M+14.8%
2018Dec 31, 2018$141.10M+18.5%
2017Dec 29, 2017$119.03M+313.3%
2016Dec 30, 2016$28.80M-26.6%
2015Dec 31, 2015$39.24M-48.9%
2014Dec 31, 2014$76.77M-46.2%
2013Dec 31, 2013$142.62M+335.7%
2012Dec 31, 2012$32.73M-55.7%
2011Dec 30, 2011$73.83M–

More Galectin Therapeutics figures

See a number that looks wrong?